Skip to main content
OpenTrials

Clinical trial condition

Recurrence

Explore clinical trials studying Recurrence. Study availability and eligibility vary by location and protocol.

2,310 public trials 520 recruiting studies
Refine in advanced search Browse all conditions

Recurrence trial results

Active, Not Recruiting

Study to Evaluate Adverse Events, Change in Disease Activity, and How Oral ABBV-101 Moves Through the Body in Adult Participants With B-Cell Malignancies

NCT05753501

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +31 more
Locations
  • Arizona Oncology - Tucson - Wilmot Road /ID# 252351 Tucson, Arizona, United States
  • UC Irvine Medical Center /ID# 263020 Orange, California, United States
  • Stanford University - Palo Alto /ID# 249683 Palo Alto, California, United States
  • Rocky Mountain Cancer Centers - Lone Tree /ID# 252237 Lone Tree, Colorado, United States
View all 51 locations
View Trial Details
Active, Not Recruiting

Oxaliplatin ± Nivolumab in Combination With Trifluridine/Tipiracil or 5-fluorouracile in Frail Patients With Advanced, Recurrent or Metastatic Gastric, Oesophageal or Gastroesophageal Junction Cancer

NCT05476796

Conditions
Adenocarcinoma, Adenocarcinoma Of Esophagus, Carcinoma, +12 more
Locations
  • Clinique de l'Europe Amiens, France
  • Hopital Privé Arras Les Bonnettes Arras, France
  • Institut Sainte Catherine Avignon, France
  • Centre Hospitalier de Beauvais Beauvais, France
View all 28 locations
View Trial Details
Active, Not Recruiting

Combination Therapy With Entinostat and Pembrolizumab in Relapsed and Refractory Lymphomas

NCT03179930

Conditions
Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
Locations
  • Northwestern University (Data Collection Only) Evanston, Illinois, United States
  • Memorial Sloan Kettering Basking Ridge Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen Montvale, New Jersey, United States
View Trial Details
Active, Not Recruiting

Study to Evaluate Imetelstat (GRN163L) in Participants With International Prognostic Scoring System (IPSS) Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS)

NCT02598661

Conditions
Bone Marrow Diseases, Disease Attributes, Hematologic Diseases, +5 more
Locations
  • UAB Comprehensive Cancer Center Birmingham, Alabama, United States
  • Acrc/Arizona Clinical Research, Inc. Tucson, Arizona, United States
  • CBCC Global Research, Inc. Bakersfield, California, United States
  • UCLA Ronald Regan Medical Center Los Angeles, California, United States
View all 126 locations
View Trial Details
Active, Not Recruiting

A Study Evaluating the Efficacy and Safety of Mosunetuzumab in Combination With Lenalidomide in Comparison to Rituximab in Combination With Lenalidomide With a US Extension of Mosunetuzumab in Combination With Lenalidomide in Participants With Follicular Lymphoma

NCT04712097

Conditions
Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • Winship Cancer Institute Atlanta, Georgia, United States
  • Fort Wayne Medical Oncology and Hematology, Inc Fort Wayne, Indiana, United States
  • Investigative Clinical Research of Indiana, LLC Noblesville, Indiana, United States
View all 112 locations
View Trial Details

Related conditions